Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 PASI score  





2 Ultraviolet info seems self-contradictory  





3 Mention the generic (calcitriol) along with the patented (calcipotriol)?  





4 Improvement suggestion from a person editing with IP address  
2 comments  




5 Lancet seminar  
2 comments  













Talk:Psoriasis




Page contents not supported in other languages.  









Article
Talk
 

















Read
Edit
Add topic
View history
 








Tools
   


Actions  



Read
Edit
Add topic
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Get shortened URL
Download QR code
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


PASI score[edit]

PASI stands for Psoriasis Area and Severity Index. PASI includes the amount of body surface area that is affected by psoriasis in addition to three major symptoms: redness, inflammation, and the thickness of the scale on the skin. A patient is given a PASI score from 0-72 where 0 means no psoriasis and 72 means the most severe psoriasis. A PASI score is given to a patient before treatment and then after treatment to determine the effectiveness of the therapy. The goal of successful psoriasis treatment is to reduce the PASI score as close to 0 (no psoriasis) as possible.

Ultraviolet info seems self-contradictory[edit]

Ultraviolet wavelengths are subdivided into UVA (380–315 nm), UVB (315–280 nm), and UVC (< 280 nm). Ultraviolet B (UVB) (315–280 nm) is absorbed by the epidermis and has a beneficial effect on psoriasis. Narrowband UVB (311 to 312 nm), is that part of the UVB spectrum that is most helpful for psoriasis.

Query: If UVA is from 380-315 nm, it includes 311-312 nm. So how come Narrowband UV (311 to 312 nm) is supposed to be UVB instead of UVA?

Answer: 380-315nm does not included 311-312nm. 311-312 is less than 315.

Mention the generic (calcitriol) along with the patented (calcipotriol)?[edit]

Moisturizers and emollients such as mineral oil, petroleum jelly, calcipotriol orcalcitriol, and decubal (an oil-in-water emollient) were found to increase the clearance of psoriatic plaques. Emollients have been shown to be even more effective at clearing psoriatic plaques when combined with phototherapy.[1] However, certain emollients have no impact on psoriasis plaque clearance or may even decrease the clearance achieved with phototherapy. The emollient salicylic acid is structurally similar to para-aminobenzoic acid (PABA), commonly found in sunscreen, and is known to interfere with phototherapy in psoriasis. Coconut oil, when used as an emollient in psoriasis, has been found to decrease plaque clearance with phototherapy.[1] Medicated creams and ointments applied directly to psoriatic plaques can help reduce inflammation, remove built-up scale, reduce skin turnover, and clear affected skin of plaques. Ointment and creams containing coal tar, dithranol, corticosteroids (i.e. desoximetasone), fluocinonide, vitamin D3 analogs (for example, calcipotriol or calcitriol), and retinoids are routinely used. The use of the finger tip unit may be helpful in guiding how much topical treatment to use.[2][3]


References

  1. ^ a b Asztalos ML, Heller MM, Lee ES, Koo J (May 2013). "The impact of emollients on phototherapy: a review". J Am Acad Dermatol. 68 (5): 817–24. doi:10.1016/j.jaad.2012.05.034. PMID 23399460.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • ^ Cite error: The named reference Clarke2011 was invoked but never defined (see the help page).
  • ^ Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R; American Academy of Dermatology (2009). "Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies". J Am Acad Dermatol. 60 (4): 643–59. doi:10.1016/j.jaad.2008.12.032. PMID 19217694.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Improvement suggestion from a person editing with IP address[edit]

    Hi, I was just reviewing a recent edit made by someone from an IP address that suggested we include the following evidence in the article:

    This looks like an interesting research paper. Adding evidence to Wikipedia is a little different from an academic review article in that in most cases, Wikipedia articles only include evidence that has undergone a secondary review. I can see that this is a primary research paper that was just published a few days ago. My idea was to include this on the talk page so that we can look for a recent review that may summarize preliminary work or similar studies, or we wait for this paper to be included in a systematic review or clinical guideline (or any source appropriate for Wikipedia as per WP:MEDRS. If the person editing from an IP address has any ideas the include, this is a great place to post them! JenOttawa (talk) 13:52, 18 December 2020 (UTC)[reply]

    @MrOllie: thanks for your efforts to reach out to this editor. It is great to see content experts and researchers here to improve articles and Wikipedia. I left a message on their talk page, but I am not sure how notifications work for IP addresses. I can see that it has now been added back in. JenOttawa (talk) 14:41, 18 December 2020 (UTC)[reply]

    References

    1. ^ Macleod, Thomas; Ainscough, Joseph S.; Hesse, Christina; Konzok, Sebastian; Braun, Armin; Buhl, Anna-Lena; Wenzel, Joerg; Bowyer, Paul; Terao, Yutaka; Herrick, Sarah; Wittmann, Miriam; Stacey, Martin (December 2020). "The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues". Cell Reports. 33 (11): 108515. doi:10.1016/j.celrep.2020.108515.

    Lancet seminar[edit]

    doi:10.1016/S0140-6736(20)32549-6 JFW | T@lk 17:33, 2 April 2021 (UTC)[reply]

    How did they get 2A02:C7C:C460:4000:7974:9FE9:2B77:5CD4 (talk) 20:51, 5 November 2023 (UTC)[reply]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Psoriasis&oldid=1233145348"

    Categories: 
    Wikipedia good articles
    Natural sciences good articles
    GA-Class vital articles
    Wikipedia level-5 vital articles
    Wikipedia vital articles in Biology and health sciences
    GA-Class level-5 vital articles
    Wikipedia level-5 vital articles in Biology and health sciences
    GA-Class vital articles in Biology and health sciences
    GA-Class medicine articles
    High-importance medicine articles
    GA-Class dermatology articles
    Unknown-importance dermatology articles
    Dermatology task force articles
    GA-Class WikiProject Medicine Translation Task Force articles
    High-importance WikiProject Medicine Translation Task Force articles
    WikiProject Medicine Translation Task Force articles
    Previous MCOTM articles
    All WikiProject Medicine pages
    Wikipedia pages referenced by the press
    Hidden category: 
    Talk pages with reference errors
     



    This page was last edited on 7 July 2024, at 14:19 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki